Stromacare SAS
Karine Aguera is the Chief Development Officer at Stromacare SAS since March 2022. With a background in R&D project management and preclinical studies, she has extensive experience in overseeing the development and production of pharmaceutical products. Karine's expertise lies in coordinating CMC and preclinical data to build regulatory strategies and identify the best partners for process development. Her work history includes roles at ERYTECH Pharma and IDEALP Pharma, where she managed R&D projects and conducted in vitro tests. Karine holds a Master's degree in Biochemistry and Biochemical Engineering from Université Claude Bernard Lyon 1.
This person is not in any teams
Stromacare SAS
StromaCare is opening a new therapeutic avenue by targeting the tumoral Stroma, which is known to play a key role in several solid cancers, with the objective to be essential in the numerous anticancer protocols of treatment. Stromacare won the Beatrice Denys Foundation 2021 Prize (Foundation for Medical Research). The company is located in Lyon, France.